Compounds > dihydroergotamine
Page last updated: 2024-08-21

dihydroergotamine and Brugada ECG Pattern

dihydroergotamine has been researched along with Brugada ECG Pattern in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MORRIS, LE; NOLTENSMEYER, MH; WHITE, JM1
ORTH, OS1
BENNETT, WD; DHUNER, KG; ORTH, OS1

Other Studies

3 other study(ies) available for dihydroergotamine and Brugada ECG Pattern

ArticleYear
The influence of dihydroergotamine methanesulfonate (DHE-45) on epinephrine induced cardiac irregularities in dogs during anesthesia with several agents.
    Archives internationales de pharmacodynamie et de therapie, 1951, Volume: 88, Issue:3

    Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Dihydroergotamine; Dogs; Epinephrine; Ergot Alkaloids; Heart Conduction System

1951
The use of dihydroergotamine (D.H.E. 45) and dihydroergocornine (D.H.O. 180) to prevent cardiac irregularities during cyclopropane anesthesia.
    Archives internationales de pharmacodynamie et de therapie, 1949, Jan-01, Volume: 78, Issue:1

    Topics: Anesthesia; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Cyclopropanes; Dihydroergocornine; Dihydroergotamine; Heart Conduction System; Humans

1949
A comparison of the effectiveness of dihydroergotamine (DHE-45) and dihydroergocornine (DHO-180) in the prevention of cardiac irregularities during cyclopropane anesthesia.
    The Journal of pharmacology and experimental therapeutics, 1949, Volume: 95, Issue:3

    Topics: Anesthesia; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Cyclopropanes; Dihydroergocornine; Dihydroergotamine; Heart Conduction System; Heart Rate; Humans

1949